Zacks Investment Management’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q2
Sell
-18,002
Closed -$254K 657
2017
Q1
$254K Buy
+18,002
New +$254K 0.01% 525